ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
7,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
8,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
8,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
10,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
13,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
13,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
15,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
17,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
18,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
18,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
18,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
19,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
20,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
21,2,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
22,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
23,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
24,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
26,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
26,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
27,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
28,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
29,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
30,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
31,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
32,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
32,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
32,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
33,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
33,2,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
33,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
33,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
34,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
35,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
35,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
36,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
37,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
37,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
37,3,Atrophy,Trophic disorders,Tissue disorders NEC,Genrl,N
37,4,Death,Death and sudden death,Fatal outcomes,Genrl,N
37,5,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
37,6,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
37,7,Faeces hard,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
37,8,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
37,9,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
37,10,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
37,11,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
37,12,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
37,13,Metabolic alkalosis,Metabolic alkaloses,Acid-base disorders,Metab,N
37,14,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
37,15,Organ failure,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
37,16,Pleural calcification,Pleural conditions NEC,Pleural disorders,Resp,N
37,17,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
37,18,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
37,19,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
37,20,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
37,21,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
37,22,Subdural hygroma,Structural brain disorders NEC,Structural brain disorders,Nerv,N
37,23,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
37,24,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
38,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
38,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
40,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
40,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
41,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
